Treatment options for air pollutant-driven airway disease

Sundeep Santosh Salvi (Pune (Maharashtra), India)

Source: International Congress 2017 – Effects of air pollution on asthma and COPD
Session: Effects of air pollution on asthma and COPD
Session type: Symposium
Number: 4391
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sundeep Santosh Salvi (Pune (Maharashtra), India). Treatment options for air pollutant-driven airway disease. International Congress 2017 – Effects of air pollution on asthma and COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of airway disease
Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK
Year: 2016


Air pollution and inflammatory airway disease: therapeutic options
Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=262
Year: 2002

Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016

Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016

Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Poor adherence to ICS treatment in patients with chronic respiratory diseases
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013

Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?
Source: Eur Respir J 2015; 46: 287-288
Year: 2015


Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Measuring adherence to therapy in airways disease
Source: Breathe, 17 (2) 210037; 10.1183/20734735.0037-2021
Year: 2021



Small airway disease and tidal airway closure in end-stage liver disease patients
Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases
Year: 2009


Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015

Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014

Are ultrafine particle inhalers, better for patients with small airway involvement?
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014


Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Management of chronic airway infection in bronchiectasis
Source: Virtual Congress 2020 – The future of bronchiectasis management
Year: 2020


Poverty cannot be inhaled and it is not a genetic condition. How can it be associated with chronic airflow obstruction?
Source: Eur Respir J, 49 (6) 1700823; 10.1183/13993003.00823-2017
Year: 2017